References
- Aanouz, I., Belhassan, A., El-Khatabi, K., Lakhlifi, T., El-Ldrissi, M., & Bouachrine, M. (2020). Moroccan Medicinal plants as inhibitors against SARS-CoV-2 main protease: Computational investigations. Journal of Biomolecular Structure & Dynamics, 1–9. https://doi.org/https://doi.org/10.1080/07391102.2020.1758790
- Arabi, Y. M., Asiri, A. Y., Assiri, A. M., Aziz Jokhdar, H. A., Alothman, A., Balkhy, H. H., AlJohani, S., Al Harbi, S., Kojan, S., Al Jeraisy, M., Deeb, A. M., Memish, Z. A., Ghazal, S., Al Faraj, S., Al-Hameed, F., AlSaedi, A., Mandourah, Y., Al Mekhlafi, G. A., Sherbeeni, N. M., … Hussein, M. A, … the Saudi Critical Care Trials group (2020). Treatment of Middle East respiratory syndrome with a combination of lopinavir/ritonavir and interferon-β1b (MIRACLE trial): Statistical analysis plan for a recursive two-stage group sequential randomized controlled trial. Trials, 21(1), 8. https://doi.org/https://doi.org/10.1186/s13063-019-3846-x
- Bennardo, F., Buffone, C., & Giudice, A. (2020). New therapeutic opportunities for COVID-19 patients with Tocilizumab: Possible correlation of interleukin-6 receptor inhibitors with osteonecrosis of the jaws. Oral Oncology, 106, 104659. https://doi.org/https://doi.org/10.1016/j.oraloncology.2020.104659
- Cao, B., Wang, Y., Wen, D., Liu, W., Wang, J., Fan, G., Ruan, L., Song, B., Cai, Y., Wei, M., Li, X., Xia, J., Chen, N., Xiang, J., Yu, T., Bai, T., Xie, X., Zhang, L., Li, C., … Wang, C. (2020). A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19. The New England Journal of Medicine, 382(19), 1787–1799. https://doi.org/https://doi.org/10.1056/NEJMoa2001282
- Case, D. A., Babin, V., Berryman, J. T., Betz, R. M., Cai, Q., Cerutti, D. S., Cheatham, T. E., Darden, T. A., Duke, R. E., Gohlke, H., Goetz, A. W., Gusarov, S., Homeyer, N., Janowski, P., Kaus, J., Kolossváry, I., Kovalenko, A., Lee, T. S., LeGrand, S., … Kollman, P. A. (2014). AMBER 14. University of California.
- Cheatham, T. I., Miller, J. L., Fox, T., Darden, T. A., & Kollman, P. A. (1995). Molecular dynamics simulations on solvated biomolecular systems: The particle mesh Ewald method leads to stable trajectories of DNA, RNA, and proteins. Journal of the American Chemical Society, 117(14), 4193–4194. https://doi.org/https://doi.org/10.1021/ja00119a045
- Cieplak, P., Cornell, W. D., Bayly, C., & Kollman, P. A. (1995). Application of the multimolecule and multiconformational RESP methodology to biopolymers: Charge derivation for DNA, RNA, and proteins. Journal of Computational Chemistry, 16(11), 1357–1377. https://doi.org/https://doi.org/10.1002/jcc.540161106
- Cornell, W. D., Cieplak, P., Bayly, C. I., Gould, I. R., Merz, K. M., Ferguson, D. M., Spellmeyer, D. C., Fox, T., Caldwell, J. W., & Kollman, P. A. (1995). A second generation force field for the simulation of proteins, nucleic acids, and organic molecules. Journal of the American Chemical Society, 117(19), 5179–5197. https://doi.org/https://doi.org/10.1021/ja00124a002
- da Costa, V. G., Moreli, M. L., & Saivish, M. V. (2020). The emergence of SARS, MERS and novel SARS-2 coronaviruses in the 21st century. Archives of Virology, 165(7), 1517–1510. https://doi.org/https://doi.org/10.1007/s00705-020-04628-0
- DeLano, W. L. (2002). Pymol: An open-source molecular graphics tool. CCP4 Newsletter on Protein Crystallography, 40, 82–92.
- Den Boon, J. A., Diaz, A., & Ahlquist, P. (2010). Cytoplasmic viral replication complexes. Cell Host & Microbe, 8(1), 77–85. https://doi.org/10.1016/j.chom.2010.06.010.
- Drosten, C., Günther, S., Preiser, W., van der Werf, S., Brodt, H.-R., Becker, S., Rabenau, H., Panning, M., Kolesnikova, L., Fouchier, R. A. M., Berger, A., Burguière, A.-M., Cinatl, J., Eickmann, M., Escriou, N., Grywna, K., Kramme, S., Manuguerra, J.-C., Müller, S., … Doerr, H. W. (2003). Identification of a novel coronavirus in patients with severe acute respiratory syndrome. The New England Journal of Medicine, 348(20), 1967–1976. https://doi.org/https://doi.org/10.1056/NEJMoa030747
- Elfiky, A. A. (2020a). Anti-HCV, nucleotide inhibitors, repurposing against COVID-19. Life Sciences, 248, 117477https://doi.org/https://doi.org/10.1016/j.lfs.2020.117477
- Elfiky, A. A. (2020b). Ribavirin, remdesivir, sofosbuvir, galidesivir, and tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study. Life Sciences, 253, 117592https://doi.org/https://doi.org/10.1016/j.lfs.2020.117592
- Ferner, R. E., & Aronson, J. K. (2020). Chloroquine and hydroxychloroquine in covid-19. BMJ (Clinical Research ed.).), 369, m1432. https://doi.org/https://doi.org/10.1136/bmj.m1432
- Friesner, R. A., Murphy, R. B., Repasky, M. P., Frye, L. L., Greenwood, J. R., Halgren, T. A., Sanschagrin, P. C., & Mainz, D. T. (2006). Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. Journal of Medicinal Chemistry, 49(21), 6177–6196. https://doi.org/https://doi.org/10.1021/jm051256o
- Gohlke, H., & Case, D. A. (2004). Converging free energy estimates: MM-PB(GB)SA studies on the protein-protein complex Ras-Raf . Journal of Computational Chemistry, 25(2), 238–250. https://doi.org/https://doi.org/10.1002/jcc.10379
- Gupta, M. K., Vemula, S., Donde, R., Gouda, G., Behera, L., & Vadde, R. (2020). In-silico approaches to detect inhibitors of the human severe acute respiratory syndrome coronavirus envelope protein ion channel. Journal of Biomolecular Structure & Dynamics, 1–11. https://doi.org/https://doi.org/10.1080/07391102.2020.175130032238078
- Hackbart, M., Deng, X., & Baker, S. C. (2020). Coronavirus endoribonuclease targets viral polyuridine sequences to evade activating host sensors. Proceedings of the National Academy of Sciences of the United States of America, 117(14), 8094–8103. https://doi.org/https://doi.org/10.1073/pnas.1921485117
- Hamelberg, D., Mongan, J., & McCammon, J. A. (2004). Accelerated molecular dynamics: A promising and efficient simulation method for biomolecules. The Journal of Chemical Physics, 120(24), 11919–11929. https://doi.org/https://doi.org/10.1063/1.1755656
- Harder, E., Damm, W., Maple, J., Wu, C., Reboul, M., Xiang, J. Y., Wang, L., Lupyan, D., Dahlgren, M. K., Knight, J. L., Cerutti, D. S., Krilov, G., Jorgensen, W. L., Abel, R., Friesner, R. A., & Kaus, J. W. (2016). OPLS3: A force field providing broad coverage of drug-like small molecules and proteins. Journal of Chemical Theory and Computation, 12(1), 281–296. https://doi.org/https://doi.org/10.1021/acs.jctc.5b00864
- Hendaus, M. A. (2020). Remdesivir in the treatment of coronavirus disease 2019 (COVID-19): A simplified summary. Journal of Biomolecular Structure & Dynamics, 1–6. https://doi.org/https://doi.org/10.1080/07391102.2020.176769132396771
- Irwin, J. J., & Shoichet, B. K. (2005). ZINC-a free database of commercially available compounds for virtual screening. Journal of Chemical Information and Modeling, 45(1), 177–182. https://doi.org/https://doi.org/10.1021/ci049714+
- Joshi, R. S., Jagdale, S. S., Bansode, S. B., Shankar, S. S., Tellis, M. B., Pandya, V. K., Chugh, A., Giri, A. P., & Kulkarni, M. J. (2020). Discovery of potential multi-target-directed ligands by targeting host-specific SARS-CoV-2 structurally conserved main protease. Journal of Biomolecular Structure & Dynamics, 1–16. https://doi.org/https://doi.org/10.1080/07391102.2020.176013732329408
- Khan, S. A., Zia, K., Ashraf, S., Uddin, R., & Ul-Haq, Z. (2020). Identification of chymotrypsin-like protease inhibitors of SARS-CoV-2 via integrated computational approach. Journal of Biomolecular Structure & Dynamics, 1–10. https://doi.org/https://doi.org/10.1080/07391102.2020.175129832238094
- Li, X., Wang, W., Zhao, X., Zai, J., Zhao, Q., Li, Y., & Chaillon, A. (2020). Transmission dynamics and evolutionary history of 2019-nCoV. Journal of Medical Virology, 92(5), 501–511. https://doi.org/https://doi.org/10.1002/jmv.25701
- Luo, P., Liu, Y., Qiu, L., Liu, X., Liu, D., & Li, J. (2020). Tocilizumab treatment in COVID-19: A single center experience. Journal of Medical Virology, 92(7), 814–818. https://doi.org/https://doi.org/10.1002/jmv.25801
- Maier, J. A., Martinez, C., Kasavajhala, K., Wickstrom, L., Hauser, K. E., & Simmerling, C. (2015). ff14SB: Improving the accuracy of protein side chain and backbone parameters from ff99SB. Journal of Chemical Theory and Computation, 11(8), 3696–3713. https://doi.org/https://doi.org/10.1021/acs.jctc.5b00255
- Menachery, V. D., Debbink, K., & Baric, R. S. (2014). Coronavirus non-structural protein 16: Evasion, attenuation, and possible treatments. Virus Research, 194, 191–199. https://doi.org/https://doi.org/10.1016/j.virusres.2014.09.009
- Menachery, V. D., Yount, B. L., Josset, L., Gralinski, L. E., Scobey, T., Agnihothram, S., Katze, M. G., & Baric, R. S. (2014). Attenuation and restoration of severe acute respiratory syndrome coronavirus mutant lacking 2'-o-methyltransferase activity . Journal of Virology, 88(8), 4251–4264. https://doi.org/https://doi.org/10.1128/JVI.03571-13
- Michot, J.-M., Albiges, L., Chaput, N., Saada, V., Pommeret, F., Griscelli, F., Balleyguier, C., Besse, B., Marabelle, A., Netzer, F., Merad, M., Robert, C., Barlesi, F., Gachot, B., & Stoclin, A. (2020). Tocilizumab, an anti-IL-6 receptor antibody, to treat COVID-19-related respiratory failure: A case report. Annals of Oncology: Official Journal of the European Society for Medical Oncology, 31(7), 961–964. https://doi.org/https://doi.org/10.1016/j.annonc.2020.03.300
- Muralidharan, N., Sakthivel, R., Velmurugan, D., & Gromiha, M. M. (2020). Computational studies of drug repurposing and synergism of lopinavir, oseltamivir and ritonavir binding with SARS-CoV-2 Protease against COVID-19. Journal of Biomolecular Structure and Dynamics, 1–7. https://doi.org/https://doi.org/10.1080/07391102.2020.1752802
- Onufriev, A., Bashford, D., & Case, D. A. (2000). Modification of the generalized Born model suitable for macromolecules. The Journal of Physical Chemistry B, 104(15), 3712–3720. https://doi.org/https://doi.org/10.1021/jp994072s
- Pant, S., Singh, M., Ravichandiran, V., Murty, U. S. N., & Srivastava, H. K. (2020). Peptide-like and small-molecule inhibitors against Covid-19. Journal of Biomolecular Structure & Dynamics, 1–10. https://doi.org/https://doi.org/10.1080/07391102.2020.175751032306822
- Ramanathan, A., Robb, G. B., & Chan, S. H. (2016). mRNA capping: Biological functions and applications. Nucleic Acids Research, 44(16), 7511–7526. https://doi.org/https://doi.org/10.1093/nar/gkw551
- Roe, D. R., & Cheatham, T. E. III, (2013). PTRAJ and CPPTRAJ: software for processing and analysis of molecular dynamics trajectory data. Journal of Chemical Theory and Computation, 9(7), 3084–3095. https://doi.org/https://doi.org/10.1021/ct400341p
- Rosa, S. G. V., & Santos, W. C. (2020). Clinical trials on drug repositioning for COVID-19 treatment. Revista Panamericana de Salud Publica = Pan American Journal of Public Health, 44, e40. https://doi.org/https://doi.org/10.26633/RPSP.2020.40
- Rosas-Lemus, M., Minasov, G., Shuvalova, L., Inniss, N. L., Kiryukhina, O., Wiersum, G., … Jaroszewski, L. (2020). The crystal structure of nsp10-nsp16 heterodimer from SARS-CoV-2 in complex with S-adenosylmethionine. bioRxiv. https://doi.org/https://doi.org/10.1101/2020.04.17.047498
- Sahraei, Z., Shabani, M., Shokouhi, S., & Saffaei, A. (2020). Aminoquinolines against coronavirus disease 2019 (COVID-19): Chloroquine or hydroxychloroquine. International Journal of Antimicrobial Agents, 55(4), 105945. https://doi.org/https://doi.org/10.1016/j.ijantimicag.2020.105945
- Salentin, S., Schreiber, S., Haupt, V. J., Adasme, M. F., & Schroeder, M. (2015). PLIP: Fully automated protein-ligand interaction profiler. Nucleic Acids Research, 43(W1), W443–W447. https://doi.org/https://doi.org/10.1093/nar/gkv315
- Sarma, P., Shekhar, N., Prajapat, M., Avti, P., Kaur, H., Kumar, S., Singh, S., Kumar, H., Prakash, A., Dhibar, D. P., & Medhi, B. (2020). In-silico homology assisted identification of inhibitor of RNA binding against 2019-nCoV N-protein (N terminal domain). Journal of Biomolecular Structure & Dynamics, 1–9. https://doi.org/https://doi.org/10.1080/07391102.2020.175358032266867
- Sastry, G. M., Adzhigirey, M., Day, T., Annabhimoju, R., & Sherman, W. (2013). Protein and ligand preparation: Parameters, protocols, and influence on virtual screening enrichments. Journal of Computer-Aided Molecular Design, 27(3), 221–234. https://doi.org/https://doi.org/10.1007/s10822-013-9644-8
- Scuccimarri, R., Sutton, E., & Fitzcharles, M. A. (2020). Hydroxychloroquine: A potential ethical dilemma for rheumatologists during the COVID-19 pandemic. The Journal of Rheumatology, 47(6), 783–786. https://doi.org/https://doi.org/10.3899/jrheum.200369
- Sinha, S. K., Shakya, A., Prasad, S. K., Singh, S., Gurav, N. S., Prasad, R. S., & Gurav, S. S. (2020). An in-silico evaluation of different Saikosaponins for their potency against SARS-CoV-2 using NSP15 and fusion spike glycoprotein as targets. Journal of Biomolecular Structure & Dynamics, 1–12. https://doi.org/https://doi.org/10.1080/07391102.2020.176274132345124
- Sodhi, M., & Etminan, M. (2020). Therapeutic potential for tetracyclines in the treatment of COVID-19. Pharmacotherapy, 40(5), 487–488. https://doi.org/https://doi.org/10.1002/phar.2395
- URL: https://www.specs.net/index.php#aboutspecs
- Vanquelef, E., Simon, S., Marquant, G., Garcia, E., Klimerak, G., Delepine, J. C., Cieplak, P., & Dupradeau, F. Y. (2011). RED Server: A web service for deriving RESP and ESP charges and building force field libraries for new molecules and molecular fragments. Nucleic Acids Research, 39(Web Server issue), W511–W517. https://doi.org/https://doi.org/10.1093/nar/gkr288
- Wang, Y., Sun, Y., Wu, A., Xu, S., Pan, R., Zeng, C., Jin, X., Ge, X., Shi, Z., Ahola, T., Chen, Y., & Guo, D. (2015). Coronavirus nsp10/nsp16 methyltransferase can be targeted by nsp10-derived peptide in vitro and in vivo to reduce replication and pathogenesis. Journal of Virology, 89(16), 8416–8427. https://doi.org/https://doi.org/10.1128/JVI.00948-15
- Wishart, D. S., Knox, C., Guo, A. C., Cheng, D., Shrivastava, S., Tzur, D., Gautam, B., & Hassanali, M. (2008). DrugBank: A knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Research, 36(Database issue), D901–D906. https://doi.org/https://doi.org/10.1093/nar/gkm958
- Yang, D., & Leibowitz, J. L. (2015). The structure and functions of coronavirus genomic 3' and 5' ends. Virus Research, 206, 120–133. https://doi.org/https://doi.org/10.1016/j.virusres.2015.02.025
- Yuen, K. S., Ye, Z. W., Fung, S. Y., Chan, C. P., & Jin, D. Y. (2020). SARS-CoV-2 and COVID-19: The most important research questions. Cell & Bioscience, 10(1), 40–45. https://doi.org/https://doi.org/10.1186/s13578-020-00404-4
- Zaki, A. M., Van Boheemen, S., Bestebroer, T. M., Osterhaus, A. D., & Fouchier, R. A. (2012). Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. The New England Journal of Medicine, 367(19), 1814–1820. https://doi.org/https://doi.org/10.1056/NEJMoa1211721
- Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., Niu, P., Zhan, F., Ma, X., Wang, D., Xu, W., Wu, G., Gao, G. F., & Tan, W. (2020). A novel coronavirus from patients with pneumonia in China, 2019. The New England Journal of Medicine, 382(8), 727–733. https://doi.org/https://doi.org/10.1056/NEJMoa2001017